Pharmaceuticals News

Study met primary endpoint of change from baseline in the ratio of Vh:Cd (p=0.0176)First Phase 2 evidence that blocking CD122 can prevent gluten-induced intestinal damage in people living with...

The Botswana subsidiary expands Bio Usawa’s international presence, joining the company’s existing operations in Rwanda, Kenya, and Germany.

Optogenetic therapy proved safe in blind patients and led to a clinically meaningful increase in light sensitivity in six, marking a major milestone.

Lifecore Biomedical to Participate at Upcoming Industry Conferences

HIGH POINT, N.C., Oct. 07, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for...

Lyon (France), October 07, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that, following a further benefit-risk assessment of IXCHIQ® for...

Lyon (France), le 7 octobre 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui qu’à la suite d’une nouvelle évaluation du rapport...

Company announcement – No. 54 / 2026 Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes ...

Greenline Pajaro Dispensary grand opening: Fri 10/9 at 1 PM in Watsonville! 10 years of award-winning, locally grown cannabis at great prices.

Company AnnouncementCOPENHAGEN, Denmark; October 7, 2026 – Genmab A/S (Nasdaq: GMAB) Today, Genmab A/S held an Extraordinary General Meeting.At the Extraordinary General Meeting the proposal from the...